MAM
Monaco Asset Management Portfolio holdings
AUM
$264M
This Quarter Return
-2.61%
1 Year Return
+6.34%
3 Year Return
+31.77%
5 Year Return
–
10 Year Return
–
AUM
$186M
AUM Growth
+$186M
(-17%)
Cap. Flow
-$33.5M
Cap. Flow
% of AUM
-18.03%
Top 10 Holdings %
Top 10 Hldgs %
56.65%
Holding
80
New
13
Increased
22
Reduced
15
Closed
14
Top Buys
| 1 |
UBS Group
UBS
|
$7.33M |
| 2 |
Teva Pharmaceuticals
TEVA
|
$7.04M |
| 3 |
Hecla Mining
HL
|
$6.18M |
| 4 |
Agnico Eagle Mines
AEM
|
$6.08M |
| 5 |
Nektar Therapeutics
NKTR
|
$5.33M |
Top Sells
| 1 |
Sprott Physical Gold
PHYS
|
$18.5M |
| 2 |
SPDR Gold Trust
GLD
|
$15M |
| 3 |
TechnipFMC
FTI
|
$11M |
| 4 |
AUY
Yamana Gold, Inc.
AUY
|
$9.21M |
| 5 |
Tidewater
TDW
|
$9.04M |
Sector Composition
| 1 | Healthcare | 30.2% |
| 2 | Materials | 17.08% |
| 3 | Technology | 13.36% |
| 4 | Financials | 9.15% |
| 5 | Consumer Discretionary | 7.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
VanEck Gold Miners ETF
GDX
$19B
| $22.6M | 6.3% |
750,000
-100,000
| -12% | -$3.01M |
|
2
Viatris
VTRS
$12.3B
| $15.7M | 4.39% |
1,575,000
-25,000
| -2% | -$250K |
|
3
Zoom
ZM
$24.4B
| $11.9M | 3.32% |
175,000
+12,500
| +8% | +$849K |
|
4
Alibaba
BABA
$322B
| $10.1M | 2.82% |
121,000
-40,000
| -25% | -$3.33M |
|
|
5
Hecla Mining
HL
$5.7B
| $9.27M | 2.59% |
1,800,000
+1,200,000
| +200% | +$6.18M |
|
6
StoneCo
STNE
$4.41B
| $9.11M | 2.54% |
715,000
-185,000
| -21% | -$2.36M |
|
|
7
UBS Group
UBS
$128B
| $7.33M | 2.04% |
+362,450
| New | +$7.33M |
|
|
8
Teva Pharmaceuticals
TEVA
$21.1B
| $7.04M | 1.96% |
+934,413
| New | +$7.04M |
|
9
PayPal
PYPL
$67.1B
| $6.34M | 1.77% |
95,000
+70,000
| +280% | +$4.67M |
|
|
10
Agnico Eagle Mines
AEM
$72.4B
| $6.08M | 1.7% |
+121,720
| New | +$6.08M |
|
|
11
Nektar Therapeutics
NKTR
$568M
| $5.33M | 1.49% |
+9,260,717
| New | +$5.33M |
|
|
CMRX
12
DELISTED
Chimerix, Inc.
CMRX
| $5.3M | 1.48% |
4,377,674
+1,992,299
| +84% | +$2.41M |
|
13
Pan American Silver
PAAS
$12.3B
| $4.98M | 1.39% |
341,685
+316,685
| +1,267% | +$4.62M |
|
14
Fate Therapeutics
FATE
$120M
| $4.78M | 1.34% |
1,005,226
+34,933
| +4% | +$166K |
|
15
Zymeworks
ZYME
$1.12B
| $3.54M | 0.99% |
409,520
+10,420
| +3% | +$90K |
|
16
Alamos Gold
AGI
$12.8B
| $3.53M | 0.98% |
295,836
-135,000
| -31% | -$1.61M |
|
17
LendingTree
TREE
$925M
| $3.36M | 0.94% |
151,890
+72,641
| +92% | +$1.61M |
|
18
Sibanye-Stillwater
SBSW
$5.36B
| $3.18M | 0.89% |
509,358
+385,000
| +310% | +$2.4M |
|
19
Valaris
VAL
$3.54B
| $3.15M | 0.88% |
50,000
+2,500
| +5% | +$157K |
|
20
Inogen
INGN
$216M
| $2.94M | 0.82% |
+254,611
| New | +$2.94M |
|
21
Oric Pharmaceuticals
ORIC
$994M
| $2.94M | 0.82% |
378,222
-173,527
| -31% | -$1.35M |
|
|
FTCH
22
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $2.72M | 0.76% |
450,000
+25,000
| +6% | +$151K |
|
23
JD.com
JD
$44.1B
| $2.57M | 0.72% |
75,426
+20,426
| +37% | +$697K |
|
24
DNOW Inc
DNOW
$1.68B
| $2.39M | 0.67% |
230,332
+60,000
| +35% | +$622K |
|
25
Baidu
BIDU
$32.8B
| $2.26M | 0.63% |
+16,500
| New | +$2.26M |
|